Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Roxana Dronca MD

Roxana S. Dronca MD

Professor of Oncology, Mayo Clinic College of Medicine and Science; Chair, Hematology/Oncology, Department of Medicine, Mayo Clinic Florida, Jacksonville, Florida

Dr. Roxana S. Dronca is a consultant and Chair of the Division of Hematology/Oncology in the Department of Internal Medicine at the Mayo Clinic in Jacksonville, Florida. She serves as Director of the Mayo Clinic Comprehensive Cancer Center, Florida Cancer Programs, and she also serves as a member of the Florida Executive Operations Team.

Dr. Dronca’s research interests are in the field of tumor immunology, with a particular interest in malignant melanoma and genitourinary malignancies. Her goal is to understand the interaction of immune and endocrine systems in modulating the anti-tumor immune response, study the dynamics and mechanisms of systemic immune regulation in cancer, and develop innovative approaches to cancer therapy utilizing chemotherapy and immunotherapy agents administered in an individualized fashion. She is active in education and has provided mentorship to multiple residents, fellows and faculty, among others. She holds master's faculty privileges in Clinical and Translational Science at Mayo Clinic Graduate School of Biomedical Sciences.

Dr. Dronca is a member of the Alliance for Clinical Trials in Cancer and serves on the Alliance Immuno-Oncology Advisory Committee. She is also active in the American Society of Clinical Oncology, the Society for Immunotherapy of Cancer, and the Society of Urologic Oncology, where she is a member of the Clinical Trials Consortium. She has also served as a scientist reviewer and panel chair for the Department of Defense Congressionally Directed Medical Research Program.